Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headqua⦠read more
Healthcare
Biotechnology
2 years
USD
Exclusive to Premium users
$3.19
Price+4.94%
$0.15
$476.977m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$4.138m
-
1y CAGR-
3y CAGR-
5y CAGR-$113.296m
-
1y CAGR-
3y CAGR-
5y CAGR-$0.94
-
1y CAGR-
3y CAGR-
5y CAGR$173.373m
$209.892m
Assets$36.519m
Liabilities$7.251m
Debt3.5%
-0.1x
Debt to EBITDA-$76.727m
-
1y CAGR-
3y CAGR-
5y CAGR